Navigation Links
New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
Date:9/16/2008

ARLINGTON, Va., Sept. 16 /PRNewswire-USNewswire/ -- The American Chemistry Council is aware of a new study on bisphenol A published today in the Journal of the American Medical Association that reports a statistical association between urinary bisphenol A concentrations and medical disorders in adults. As with any study, it is critically important to understand how the design of a study can limit interpretation of the study findings.

The new study is a statistical analysis that attempts to correlate urinary concentrations of bisphenol A, which reflect very recent exposure, with the incidence of cardiovascular disease and diabetes. However, the onset and development of these diseases occurred over time periods well before the bisphenol A exposure measurements were made. Because of this and other inherent limitations, the study is not capable of establishing a cause and effect relationship between bisphenol A and these health effects.

The study is primarily useful for generating hypotheses that can be tested with more appropriate experiments or analyses. As noted by the authors of the study, independent replication and follow-up studies are needed to confirm their findings and to provide evidence on whether the associations are causal. Until such work has been completed, it is premature to draw any conclusions on human health effects.

"Overall, due to inherent limitations in study design, this new study cannot support a conclusion that bisphenol A causes any disease," stated Steven G. Hentges, Ph.D. of the American Chemistry Council's Polycarbonate/BPA Global Group. "The weight of scientific evidence continues to support the conclusion of governments worldwide that bisphenol A is not a significant health concern at the trace levels present in some consumer products."

The extensive science supporting the safety of bisphenol A has been evaluated by government bodies around the world, most recently by the US Food and Drug Administration
'/>"/>

SOURCE American Chemistry Council
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies that ... that CEO Doug Godshall is scheduled ... 11:00 a.m. EDT on Monday, May 20, 2013.  The conference ... York Hotel. A live webcast of the Company,s ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... Adeona Pharmaceuticals, Inc., (AMEX: AEN ) announced ... on Tuesday, November 2, from 9 a.m. to 10 a.m., ... MI, 48108. During the Annual Shareholder Meeting, ... give an update on the Company,s activities and answer questions. ...
... Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that ... Conference in New York on November 2, 2010 at 11:25 ... Annual Healthcare Conference in New York on November 17, 2010 ... be webcast live and may be accessed through a link ...
Cached Medicine Technology:Gen-Probe to Webcast Two Upcoming Investor Presentations 2
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn ... help people get in shape, and gain a healthy life ... also is a natural fat loss system that provides people ... this fat loss diet program claimed that The Fat Loss ... keep body fat off long-term. After Shawn Stevenson launched this ...
(Date:5/19/2013)... Exciting new Skin Brushes are available ... great practice known through the ages but is a ... body brushing, has so many benefits for our health ... "We love that circulation and lymphatic systems get a ... skin, is supported through Skin Brushing." , Why is ...
(Date:5/19/2013)... GA (PRWEB) May 19, 2013 The AMTC ... 2pm at the Columbus Georgia Convention & Trade Center on ... invited to attend. AMTC auditions are free of charge. , ... starting point for hundreds of successful artists and grads like ... face for European Tombolini , Chris Young - on his ...
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... and MTA: CTIC) announced today that it has rescheduled the ... Tuesday, March 24, 2009, in order to allow additional time ... on or about February 12, 2009, to be adequately disseminated ... receive at least 20 days written notice of the special ...
... Corporation (NYSE: ORI ) announced today ... regular quarterly cash dividend of 17 cents per common share. ... shareholders of record on March 4, 2009.The latest cash dividend ... the second quarter of 2008. The rate reflects the ...
... Funding Plan Improves Access, Modernizes TechnologyWASHINGTON, Feb. 26 ... Department of Veterans Affairs (VA) expands eligibility for ... over the next five years, meets the need ... Veterans of Iraq and Afghanistan and provides the ...
... Institute for Virology and Immunology Center for AIDS Research ... next generation of HIV/AIDS researchers and clinician scientists. ... American Journal for Public Health appearing February ... website, the program focuses on overcoming challenges faced by ...
... HARRISBURG, Pa., Feb. 26 Dean Farms in New ... contamination and resumed sales of raw milk on ... Raw milk is milk that has not been pasteurized. ... have samples of their milk laboratory tested due to ...
... The following is a statement from Georges ... of the American Public Health Association:"The American Public ... members of Congress and families across the nation ... to health reform."Along with the continued emphasis on ...
Cached Medicine News:Health News:Cell Therapeutics Reschedules Special Meeting 2Health News:Cell Therapeutics Reschedules Special Meeting 3Health News:President's 2010 Budget Request Strongly Supports VA Programs 2Health News:Effective mentoring critical to HIV/AIDS research efforts 2Health News:Lawrence County Raw Milk Dairy Tests Negative For Campylobacter; Raw Milk Sales Resumed 2
... The Netmon remote monitoring service allows ... programmed and monitored from any location ... The service enhances preventive maintenance capabilities. ... access the unit (with your permission) ...
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...
The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens....
Medicine Products: